Immunology

Items 51-60 of 170

per page
Set Descending Direction
  1. Artesunate
    CAS  88495-63-0
    AG-CN2-0469
    AG-CN2-0469-M100100 mg
    CHF 70.00
    AG-CN2-0469-M500500 mg
    CHF 210.00
    AG-CN2-0469-G0011 g
    CHF 370.00
    Artesunate
  2. AZD 7545
    CAS  252017-04-2
    AG-CR1-3692
    AG-CR1-3692-M0011 mg
    CHF 50.00
    AG-CR1-3692-M0055 mg
    CHF 160.00
    AG-CR1-3692-M01010 mg
    CHF 290.00
    AZD 7545
  3. BPTES
    CAS  314045-39-1
    AG-CR1-3690
    AG-CR1-3690-M0011 mg
    CHF 35.00
    AG-CR1-3690-M0055 mg
    CHF 95.00
    AG-CR1-3690-M02525 mg
    CHF 280.00
    BPTES
  4. BQ-788 . sodium salt
    CAS  156161-89-6
    AG-CP3-0012
    AG-CP3-0012-C500500 µg
    CHF 220.00
    AG-CP3-0012-M0011 mg
    CHF 290.00
    BQ-788 . sodium salt
  5. Bradykinin
    CAS  121283-65-6 | 58-82-2 (free base)
    AG-CP3-0025
    AG-CP3-0025-M0055 mg
    CHF 35.00
    AG-CP3-0025-M02525 mg
    CHF 130.00
    Bradykinin
  6. Bumetanide
    CAS  28395-03-1
    AG-CR1-3543
    AG-CR1-3543-M250250 mg
    CHF 35.00
    AG-CR1-3543-G0011 g
    CHF 95.00
    AG-CR1-3543-G0055 g
    CHF 290.00
    Bumetanide
  7. C75 (FASN Inhibitor)
    CAS  191282-48-1
    AG-CR1-2904
    AG-CR1-2904-M0011 mg
    CHF 60.00
    AG-CR1-2904-M0055 mg
    CHF 180.00
    C75 (FASN Inhibitor)
  8. Calreticulin (human) (rec.) (His)
    AG-40A-0132
    AG-40A-0132-C01010 µg
    CHF 230.00
    AG-40A-0132-C05050 µg
    CHF 590.00
    Flow cytometric analysis of CRT on the cell surface 3.105 EL4 Thymoma cells, growing in suspension in RPMI 1640 (Gibco) supplemented medium were plated in 12-well plates and treated with mitomycin C (30mM, Sanofi Aventis)
  9. CD152 [CTLA-4] (human) (rec.) (His)
    AG-40B-0228
    AG-40B-0228-C05050 µg
    CHF 220.00
    CD152 [CTLA-4] (human) (rec.) (His)
  10. CD152 [CTLA-4] (human) (rec.) (untagged)
    AG-40B-0232
    AG-40B-0232-C05050 µg
    CHF 220.00
    CD152 [CTLA-4] (human) (rec.) (untagged)

Items 51-60 of 170

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.